Internal Server Error

PlatinumRx's Latest Cap Table

Founders own the majority of PlatinumRx's shares, accounting for 49.72%, while Fund hold 41.51%, ESOP hold 7.35% and Angel hold 1.43%. PlatinumRx's current valuation is $23.1M and the founders' net worth in PlatinumRx's shareholding is 99.4Cr. The cap table displayed below is for AFFORIS HEALTH TECHNOLOGIES PRIVATE LIMITED which is the legal entity associated with PlatinumRx.
Here is the equity structure of PlatinumRx as per the latest Cap Tables:
Shareholders Name
Post Round Holding %
Net worth
Cumulative Investment
Realised Returns
Unrealised Returns
Return Multiple
Founder
49.72%
99.4Cr
8136576
2007996
8056432
5477426
5315099
9960162
1076496
8482300
9256912
1471442
4888565
9812996
2643442
9825606
7039111
9312860
Fund
41.51%
83Cr
3945212
7450798
2157744
9521183
5648894
4914677
4182090
4020429
3915473
8510712
3607895
4167712
8855725
7618411
6738854
8901416
Angel
1.43%
2.85Cr
6
3
3
1
ESOP Pool
7.35%
14.7Cr
2010717
2177368
6013790
1402960
Total
100.00%
200Cr
8100656
4579741
8882857
7694099
lockTo unlock detailed Cap Table of PlatinumRx Sign up today!

PlatinumRx's round by round Shareholding Summary

Here is how PlatinumRx's shareholding has changed after each funding round:
SeedSeed 2Seed 3Round Stage03060100Shareholding percent
  • Founder
  • Fund
  • Enterprise
  • Angel
  • Other People
  • ESOP Pool
  • Parent Entity
  • Other Investors
Shareholders
Seed
Dec 19, 2023
Seed 2
Dec 21, 2024
Seed 3
Jun 19, 2025
Founder
67.7%
63.9%
49.7%
Fund
20.6%
24.8%
41.5%
Parent Entity
-
-
-
Angel
1.7%
1.8%
1.4%
Other People
-
-
-
ESOP Pool
10.0%
9.4%
7.3%
Enterprise
-
-
-
Other Investors
-
-
-
Total
100.0%
100.0%
100.0%
Disclaimer
View all Cap Tables of PlatinumRx

FAQs about PlatinumRx's shareholding

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford